Imunon (IMNN) Research & Development (2010 - 2026)
Imunon (IMNN) reported Research & Development of $2.34 million for Q1 2026, up 8.0% from $2.17 million a year earlier but down 6.1% from the prior quarter.
Powered by 
Analysis
Imunon (IMNN) Research & Development (2010 - 2026) Analysis & Trends
Over the twelve months ended Mar 31, 2026, Imunon's Research & Development came in at $7.95 million, down 24.3% year-over-year; for FY2025, it was $7.78 million, down 33.2% from FY2024.
- Research & Development has a five-year compound annual growth rate of -7.3% (FY2020 to FY2025).
- By year, Research & Development came in at $11.64 million in FY2024 (+3.1%), $11.29 million in FY2023 (-3.8%), $11.73 million in FY2022 (+10.5%) and $10.62 million in FY2021 (-6.4%).
- Five-year quarterly Research & Development spans a low of $1.23 million in Q2 2025 and a high of $3.55 million in Q4 2023.
- Year over year, Research & Development gained in three of the last eight quarters, with an average decline of 11.8%.
- The high point for year-over-year Research & Development in five years was Q3 2024 (growth of 66.3%); the low point was Q2 2025 (a decline of 56.5%).
- Per Business Quant data, the three quarters before Q1 2026 came in at $2.49 million (Q4 2025), $1.9 million (Q3 2025) and $1.23 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,138.33 Bn | 1,106.91 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 618.82 Bn | 537.35 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 503.36 Bn | 476.47 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 369.59 Bn | 323.96 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 298.57 Bn | 262.56 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 261.25 Bn | 234.94 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 237.35 Bn | 192.75 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 191.27 Bn | 165.47 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 170.03 Bn | 116.68 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Imunon | 6.02 Mn | 6.02 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 2.34 Mn |
| Dec 31, 2025 | 2.49 Mn |
| Sep 30, 2025 | 1.90 Mn |
| Jun 30, 2025 | 1.23 Mn |
| Mar 31, 2025 | 2.17 Mn |
| Dec 31, 2024 | 2.23 Mn |
| Sep 30, 2024 | 3.29 Mn |
| Jun 30, 2024 | 2.82 Mn |
| Mar 31, 2024 | 3.29 Mn |
| Dec 31, 2023 | 3.55 Mn |
| Sep 30, 2023 | 1.98 Mn |
| Jun 30, 2023 | 3.13 Mn |
| Mar 31, 2023 | 2.62 Mn |
| Dec 31, 2022 | 3.00 Mn |
| Sep 30, 2022 | 2.41 Mn |
| Jun 30, 2022 | 3.23 Mn |
| Mar 31, 2022 | 3.10 Mn |
| Dec 31, 2021 | 2.99 Mn |
| Sep 30, 2021 | 2.47 Mn |
| Jun 30, 2021 | 2.59 Mn |
API Access
Imunon Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=IMNN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "IMNN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=IMNN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();